MaxCyte Announces Strategic Platform License Agreement with Moonlight Bio to Advance T Cell Therapies for Solid Tumors

MaxCyte Announces Strategic Platform License Agreement with Moonlight Bio to Advance T Cell Therapies for Solid Tumors MaxCyte's Flow Electroporation(R) Technology will support efficient gene delivery to advance Moonlight Bio's engineered T cell therapies GlobeNewswire October 06, 2025 ROCKVILLE, Md., Oct. 06, 2025 (GLOBE NEWSWIRE) — MaxCyte, Inc. (Nasdaq: MXCT), a leading cell-engineering company providing […]

NKGen Biotech to Present on the Use of Troculeucel for Neurodegenerative Diseases at the XXVII World Congress of Neurology

NKGen Biotech to Present on the Use of Troculeucel for Neurodegenerative Diseases at the XXVII World Congress of Neurology GlobeNewswire October 06, 2025 SANTA ANA, Calif., Oct. 06, 2025 (GLOBE NEWSWIRE) — NKGen Biotech, Inc. (OTC: NKGN) (“NKGen” or the “Company”), a clinical-stage biotechnology company focused on the development and commercialization of innovative autologous and

Avalara Extends AI Leadership with Avi Everywhere, MCP Servers, and Global Compliance Innovations

By embedding AI agents and MCP servers into enterprise compliance workflows, Avalara is evolving compliance into a smart, interoperable global framework, that operates at unprecedented scale Avalara, Inc., the agentic tax and compliance leader, today announced breakthroughs in enterprise compliance: Avi, Avalara's AI agent is now embedded directly where userswork; cutting-edge Model Context Protocol (MCP)

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) to Present at Noble Capital Markets October 2025 Emerging Growth Virtual Equity Conference

(NasdaqGM:NRXP), WILMINGTON, Del., Oct. 06, 2025 (GLOBE NEWSWIRE) — NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) (“NRx Pharmaceuticals”, or the “Company”), a clinical-stage biopharmaceutical company, and HOPE Therapeutics, Inc., (“HOPE,” or the “Company”), an interventional psychiatry network wholly owned by NRx Pharmaceuticals, will present at the Noble Capital Markets Emerging Growth Virtual Equity Conference on October 8,

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) to Present at Noble Capital Markets October 2025 Emerging Growth Virtual Equity Conference

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) to Present at Noble Capital Markets October 2025 Emerging Growth Virtual Equity Conference GlobeNewswire October 06, 2025 WILMINGTON, Del., Oct. 06, 2025 (GLOBE NEWSWIRE) — NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) (“NRx Pharmaceuticals”, or the “Company”), a clinical-stage biopharmaceutical company, and HOPE Therapeutics, Inc., (“HOPE,” or the “Company”), an interventional psychiatry network

VanEck Debuts EMBX, Bringing Active Emerging Markets Bond Strategy with ETF Efficiency to Investors

Now trading under the ticker symbol EMBX, investors gain access to VanEck's world-class active Emerging Markets Bond team and flagship strategy with the daily transparency, intraday liquidity and efficiency of an ETF structure VanEckannounced that the VanEck Emerging Markets Bond ETF (Ticker: EMBX) begins trading today, completing its conversion from a traditional open-end mutual fund

Culligan International, United Center, Chicago Bulls and Chicago Blackhawks Demonstrate Sustainable Impact

Nearly 600,000 Single-Use Plastic Water Bottles Avoided in First Year of Partnership withInnovative Hydration Solutions at Games, Concerts, Events Culligan International, the United Center, the Chicago Bulls, and the Chicago Blackhawks today announced the results of the first year of their sustainability-focused partnership. The collaboration measurably reduced plastic waste and encouraged more sustainable habits at

Climax Foods Announces Rebrand to Bettani Farms, $6.5 Million in New Funding, and Industry Veteran Sandeep Patel as New CEO

The company's refreshed brand and strategy, boosted by additional capital, will support the launch of its proprietary Caseed™ingredient and protein-rich, dairy-free cheeses. Climax Foods, a food technology company leading breakthrough innovation in the global cheese market, today announced it has rebranded to Bettani Farms and appointed former CFO of Califia Farms, Sandeep Patel, to serve

Energy Tech Solution Launches ‘Made in America Cell Foundry’ to Accelerate Battery Development in the United States

Dr. Bruno Vanzieleghem Hired as CEO of ETS North America to Drive Innovation in Battery Startup Sector https://mma.prnewswire.com/media/2787272/Energy_Tech_Solution_logo_Logo.jpg Energy Tech Solution (ETS), a South Korea-based manufacturer of battery factory equipment, announced today the launch of the 'Made in America Cell Foundry' to help battery startups commercialize faster. North American energy storage innovators can reduce tariff

Scroll to Top